M R Partridge. Show Affiliations »
Abstract
Mesh: See more » Asthma/drug therapyAtmosphereChlorofluorocarbonsDrug Delivery SystemsHumansLung Diseases, Obstructive/drug therapyNebulizers and VaporizersOzone
Substances: See more » ChlorofluorocarbonsOzone
Year: 1994 PMID: 7809436 DOI: 10.1016/s0954-6111(05)80060-5
Source DB: PubMed Journal: Respir Med ISSN: 0954-6111 Impact factor: 3.415